Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharathi Suresh

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Theranostics|December 8, 2025
Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis <i>in vitro</i> and <i>in vivo</i>Girish Birappa, Haribalan Perumalsamy, Seok-Ho Hong, et al.
Theranostics|April 14, 2025
Targeting USP11 counteracts <i>SFTPC</i> -associated interstitial lung disease in hiPSCs-derived alveolar organoids and in vivo modelsJanardhan Keshav Karapurkar, Sripriya Rajkumar, Ji-Hye Jung, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Theranostics|December 8, 2025
Single-cell RNA sequence analysis reveals USP32 as a therapeutic target to mitigate PD-L1-driven colorectal tumorigenesis <i>in vitro</i> and <i>in vivo</i>Girish Birappa, Haribalan Perumalsamy, Seok-Ho Hong, et al.
Theranostics|April 14, 2025
Targeting USP11 counteracts <i>SFTPC</i> -associated interstitial lung disease in hiPSCs-derived alveolar organoids and in vivo modelsJanardhan Keshav Karapurkar, Sripriya Rajkumar, Ji-Hye Jung, et al.
Pageof 5